136 related articles for article (PubMed ID: 2848900)
1. Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.
Gold D; Ashley R; Solberg G; Abbo H; Corey L
J Infect Dis; 1988 Dec; 158(6):1227-34. PubMed ID: 2848900
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of systemic acyclovir treatment of genital HSV-2 infections on antibody responses to individual HSV-2 proteins.
Ashley R; Mack K; Critchlow C; Shurtleff M; Corey L
J Med Virol; 1988 Mar; 24(3):309-19. PubMed ID: 2835427
[TBL] [Abstract][Full Text] [Related]
3. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.
Ashley RL; Corey L
J Clin Invest; 1984 Mar; 73(3):681-8. PubMed ID: 6323525
[TBL] [Abstract][Full Text] [Related]
4. The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections.
Bernstein DI; Lovett MA; Bryson YJ
J Infect Dis; 1984 Jul; 150(1):7-13. PubMed ID: 6086772
[TBL] [Abstract][Full Text] [Related]
5. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence.
Bernstein DI; Stanberry LR; Harrison CJ; Shukla R; Kappes JC; Myers MG
J Infect Dis; 1987 Sep; 156(3):423-9. PubMed ID: 3039009
[TBL] [Abstract][Full Text] [Related]
7. One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.
Molin L; Ruhnek-Forsbeck M; Svennerholm B
Scand J Infect Dis Suppl; 1991; 80():33-9. PubMed ID: 1666444
[TBL] [Abstract][Full Text] [Related]
8. Serological assessment of acyclovir treatment of herpes genitalis.
Ragab NF; Habib MA; Ghozzi MY
Arch Androl; 1989; 23(2):147-53. PubMed ID: 2556084
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus.
Erlich KS; Hauer L; Mills J
J Med Virol; 1988 Sep; 26(1):33-9. PubMed ID: 3183633
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of the effects of acyclovir treatment on the HSV-2 lymphoproliferative response of persons with frequently recurring HSV-2 genital infections.
Frenkel L; Pineda E; Garratty E; Fall H; Dillon M; Bryson Y
J Infect Dis; 1989 May; 159(5):845-50. PubMed ID: 2540245
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.
Corey L; Mindel A; Fife KH; Sutherland S; Benedetti J; Adler MW
Sex Transm Dis; 1985; 12(4):215-8. PubMed ID: 3001952
[TBL] [Abstract][Full Text] [Related]
12. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
Baker DA
J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
[TBL] [Abstract][Full Text] [Related]
13. Recurrences after first episodes of genital herpes in patients treated with topical acyclovir cream.
Barton IG; Kinghorn GR; Rowland M; Jeavons M; Al-Omer LS; Potter CW
Antiviral Res; 1984 Oct; 4(5):293-300. PubMed ID: 6517563
[TBL] [Abstract][Full Text] [Related]
14. Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.
Weinberg A; Konrad M; Merigan TC
J Virol; 1987 Jul; 61(7):2120-7. PubMed ID: 3035213
[TBL] [Abstract][Full Text] [Related]
15. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group.
Kaplowitz LG; Baker D; Gelb L; Blythe J; Hale R; Frost P; Crumpacker C; Rabinovich S; Peacock JE; Herndon J
JAMA; 1991 Feb; 265(6):747-51. PubMed ID: 1990191
[TBL] [Abstract][Full Text] [Related]
16. Class-specific antibody response in acyclovir-treated and adenine arabinoside-treated patients with primary genital herpes simplex virus infection.
Kawana T; Hashido M; Koizumi Y
Microbiol Immunol; 1995; 39(10):795-9. PubMed ID: 8577270
[TBL] [Abstract][Full Text] [Related]
17. Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity.
Lehrman SN; Douglas JM; Corey L; Barry DW
Ann Intern Med; 1986 Jun; 104(6):786-90. PubMed ID: 3010782
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic herpes simplex virus shedding from the genital tract whilst on suppressive doses of oral acyclovir.
Bowman CA; Woolley PD; Herman S; Clarke J; Kinghorn GR
Int J STD AIDS; 1990 May; 1(3):174-7. PubMed ID: 1964599
[TBL] [Abstract][Full Text] [Related]
19. Continuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovir.
Goldberg LH; Kaufman RH; Kurtz TO; Conant MA; Eron LJ; Batenhorst RL; Boone GS
J Med Virol; 1993; Suppl 1():45-50. PubMed ID: 8245892
[TBL] [Abstract][Full Text] [Related]
20. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
Wade JC; Day LM; Crowley JJ; Meyers JD
J Infect Dis; 1984 May; 149(5):750-6. PubMed ID: 6327849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
